Updated on: 2020-03-28
| Response | |
|---|---|
| Q1A. What arrangements, if any, do you have in place to ensure scientific advice informs national policy and decision making in relation to Covid-19? | Several agencies under the Danish Ministry of Health employ health professionals and scientific personal (e.g. the medicines agency and the Statens Serum Institut (SSI)). These agencies inform the minister of health, just like they are available for other ministries and agencies. As an example, the SSI participate at every press briefing held by the Danish authorities concerning Covid-19. |
| Q1B. In what ways, if any, are you coordinating on Covid-19 STI responses at international level? | Denmark is a member of several international forums, where action on Covid-19 is coordinated. |
| Q2.Do you have dedicated arrangements in place for communicating science advice and for refuting misleading information to the public on Covid-19? | The site Videnskab.dk, which is publicly funded, communicates on science in general, including on Covid-19. Denmark has also launched the site coronasmitte.dk, where all information from Danish public authorities can be found. |
| Q3. What new STI policy measures, if any, is your country taking to respond specifically to the Covid-19 crisis? | The Danish government has funded research projects, which can help to create new knowledge and new solutions in the fight against Covid-19. In total DKK 50 million has been granted in a fast track model, where the deans of the four faculties of health sciences, the pro-rector of the Technical University of Denmark (DTU) and the academic director of the Statens Serum Institute (SSI) have been asked to submit proposals for Covid-19 related research projects from the researchers at their own institutions. The whole process took about one week, from call for proposals, to relevant research projects being identified, and funding granted. |
| Q4A. At national level, what mechanisms are you developing or relying upon to bring together different STI actors (researchers, industry, government, health sector, foundations, etc.) to effectively collaborate on responses to Covid-19? | [Left blank] |
| Q4B. At international level, what mechanisms are you developing or relying upon to bring together different STI actors (researchers, industry, government, health sector, foundations, etc.) to effectively collaborate on responses to Covid-19? | [Left blank] |
| Q5. What novel approaches, if any, is your country using to address the coronavirus crisis (e.g. use of machine learning, open science initiatives boosting access and sharing of data and research results, development and use of prediction models, etc.)? | [Left blank] |
| Q6A. What impact on the STI system do you anticipate in the short-, medium- and long-term, and what measures are you implementing to address those? | [Left blank] |
| Q6B. Is support of the STI system part of planned stimulus packages aimed at supporting the economy? | [Left blank] |
| Q7. Is there anything else regarding the STI policy response to Covid-19 in your country you would like to mention? | [Left blank] |